At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New York based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
David Tamburri
Managing Partner & CFO of Health Enterprise Partners
Follow David Tamburri:
About Columbia University in the City of New York, Health Enterprise Partners: Health Enterprise Partners is a private equity firm that provides its services for healthcare services and information technology companies.
Neil Edwards
Chief Financial Officer of Vesselon
Neil Edwards is the CEO of Cellufun. Edwards served as the founding CEO of dotMobi, a mobile web services company, where he grew the company from a start-up to a multi-million dollar organization. At dotMobi he built a global customer base with multiple channel platforms and content partners that generated significant recurring revenue streams. Additionally,Mr. Edwards was instrumental in building a consortium of leading mobile brands including Nokia, Vodafone, Google, Telefonica, Telecom Italia, T-Mobile, Orascom, Microsoft, Visa and many others. Prior to dotMobi, he was instrumental in the growth of VeriSign and infoUSA,having served in senior leadership positions within both organizations.
Follow Neil Edwards:
About Forbes, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Jason Klarreich
Managing Director, CFO, COO, & CCO of JW Asset Management
Jason Klarreich is the managing director, CFO, COO, and CCO at JW Asset Management. Before joining JWAM, Jason was a director and trader at Heartland Securities. He previously worked in fixed income sales at Morgan Stanley and at Smith Barney as a financial analyst in the asset management division. Jason serves on the board at Arbor Pharmaceuticals. He graduated from Emory University with a bachelor’s degree in finance.
Follow Jason Klarreich:
About JW Asset Management: JW Asset Management is a New York-based investment firm that primarily invests within the healthcare sector.
Andrew Miller
CFO of Sopris Capital Associates
Follow Andrew Miller:
About Sopris Capital Associates: Sopris Capital Associates, a U.S.-based investment firm, offers growth capital to healthcare and technology-enabled B2B service businesses.
Thomas Altier
CFO of Phreesia
Tom brings over 30 years of financial management experience to the chief financial officer role, including a “Big Four” career foundation and experience with several venture-backed, emerging-growth and SaaS businesses. As CFO of Phreesia, Tom is responsible for budgeting, forecasting, monthly reporting, financial analysis and internal controls. Prior to joining Phreesia, Tom was CFO at Perceptive Pixel, a developer of high-end, multi-touch display screens and related software, which was acquired by Microsoft in 2012. Tom is a CPA, and holds a BA and MBA from Columbia University.
Follow Thomas Altier:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Brett Kaplan
Chief Financial Officer of Prevail Therapeutics
Brett Kaplan is our Chief Financial Officer. Prior to Prevail, he was Managing Director at Evercore, where he spent eight years concentrating on biopharma M&A and equity financings. Prior to Evercore, Brett was an Equity Research Analyst at Cowen, where he covered large cap pharmaceuticals. Earlier in his career, he held senior positions at Cubist and Lilly focused on corporate and business development. Brett holds an MBBCh and an MBA from the University of Witwatersrand in South Africa.
Follow Brett Kaplan:
About Prevail Therapeutics: Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Adam Cutler
Chief Financial Officer of Molecular Templates
Adam Cutler has served as Molecular Templates’ Chief Financial Officer since November 2017.Prior to joining Molecular Templates, he was Senior Vice President of Corporate Affairs at Arbutus Biopharma from 2015-2017, where his responsibilities included investor relations, business development, and corporate finance. From 2012-2015, he was a Managing Director for The Trout Group and Trout Capital, where he executed financings and advised life science companies on investor relations, capital raising, and business development. From 2000-2011, he was a biotechnology equity research analyst at Credit Suisse, Canaccord Genuity, JMP Securities, and Bank of America Merrill Lynch. He also worked in healthcare consulting at The Frankel Group and Ernst & Young. He currently serves on the Board of Directors for Inmed Pharmaceuticals and Navidea Biopharmaceuticals. He received his B.A. in Economics from Brandeis University.
Follow Adam Cutler:
About Molecular Templates: Molecular Templates develops novel therapeutic compounds for cancer.
Bryan Perler
SVP & CFO of Sapphire Digital
Bryan has deep experience leading technology companies through fast-paced and high growth environments. As Chief Financial & Administrative Officer, Bryan is responsible for leading and guiding the organizations’ financial growth and ensuring the integrity of the data across the organization; overseeing finance, data engineering, analytics, quality, IT and facilities. Before Sapphire Digital, Bryan was the CFO and Head of Strategy at Benchmark Solutions where he oversaw all strategic, financial and legal activities for the company. He also worked at Tradeweb Markets in a variety of escalating accounting, finance and business development roles, most recently as Director of U.S. Strategy and Business Development. Bryan graduated from Lehigh University with a BS in Accounting.
Follow Bryan Perler:
About Sapphire Digital, Sapphire Digital: Sapphire Digital is a full omnichannel digital engagement and shopping platform for consumers, employers.
Amrita Bhandari
CFO of Acumen
Acumen’s focus on building a world based on dignity through creative though tangible solutions is why I am so passionate about working here.” Amrita is Acumen’s global CFO, responsible for financial operations across our geographies, strategy, planning and reporting. Prior to Acumen, Amrita was CFO of Katzenbach Partners, a dynamic management consulting firm and was instrumental in the merger integration of Katzenbach with Booz & Co. In addition to her management role, she consulted with clients across a range of industries with a focus on strategy and planning. Since then, she developed her own independent consulting practice with a focus on inspiring organizations in the social sector. Amrita has worked with Acumen in the past as a strategy consultant covering a range of topics such as clarifying Acumen’s business model, developing a multi-year operating plan and evaluating Acumen’s employee compensation plans. Amrita has also worked with Management Leadership for Tomorrow, Edelman and other professional services firms. Amrita received a BA in International Relations from The College of Wooster.
Follow Amrita Bhandari:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Gillian Munson
Chief Financial Officer of Iora Health
Follow Gillian Munson:
About Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Mark Hirschhorn
COO & CFO of Teladoc Health
Follow Mark Hirschhorn:
About Teladoc Health: Teladoc is a global provider of virtual care, transforming the access, cost, and quality dynamics of health care delivery.
Daniel Schneiderman
Chief Financial Officer of First Wave BioPharma
Follow Daniel Schneiderman:
About First Wave BioPharma: First Wave BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies.
Ali Byrd
Chief Financial Officer of Olive
Ali is a builder and leader of high-performance finance and operations for early and growth-stage companies spanning clean tech, digital music, software, fintech, marketing, and more. As a serial startup Chief Financial Officer, he has executed financial modeling, transactions, and post-merger integrations. In 1997, Ali joined Microsoft, leading developer evangelism and competitive engagement for East Coast enterprise sales and consulting teams. He later oversaw product management and the launch of Microsoft’s SharePoint business, as well as strategic planning and growth for Microsoft’s $10B Office business. He also was responsible for M&A due diligence and post-merger management for Microsoft’s venture acquisitions. Ali subsequently joined the Global Technology Investment Banking group at Lehman Brothers, providing M&A and corporate finance advisory. He later joined the next-generation biofuels company Primafuel, a World Economic Forum Technology Pioneer, where he led fundraising and infrastructure projects. In 2011, he joined SecondMarket as Senior Vice President, facilitating $2B+ in secondary transactions for the world’s best venture-backed private companies. He then joined Movable Ink as CFO, producing record growth and profitability for the marketing personalization company. He also served as CFO of Olapic, a visual marketing leader that he helped sell to Monotype in 2016. Ali earned his BSE in Electrical Engineering from Duke and is now a regional board member for Duke New York. His MBA is from the Wharton School of Business, with a concentration on finance and entrepreneurship.
Follow Ali Byrd:
About Olive: Olive develops an artificial intelligence workforce for the health care industry.
Richard Haydock
CFO of PulsePoint
Follow Richard Haydock:
About PulsePoint: PulsePoint is a technology company using data to accelerate healthcare marketing.
Richard Haydock
CFO of PulsePoint
Follow Richard Haydock:
About PulsePoint: PulsePoint is a technology company using data to accelerate healthcare marketing.
Paul Herendeen
Executive Vice President and Chief Financial Officer of Zoetis India Ltd
Paul Herendeen is executive vice president and chief financial officer (EVP and CFO) of Zoetis. In his role, Herendeen oversees the company’s Finance and Information Technology organizations and serves as part of the Zoetis Executive Team, reporting to CEO Juan Ramón Alaix. Herendeen brings more than 30 years of broad financial experience and leadership to his role at Zoetis, including 16 years as CFO of Warner Chilcott and MedPointe. From 2005 to 2013, Herendeen served as CFO at Warner Chilcott, a specialty pharmaceuticals company, which had a successful IPO in 2006, grew its revenue and profitability, and was acquired by Actavis in 2013. He joined Warner Chilcott after four years as EVP and CFO of MedPointe, a privately held health care company. He had been Warner Chilcott’s CFO from 1998 until 2000, joining the company after representing one of its lead investors on Warner Chilcott’s Board of Directors. Herendeen helped grow the company’s revenues and conduct its first successful IPO, and later helped complete the company’s acquisition by Galen PLC. From 1989 to 1998, Herendeen spent nine years as a principal investor at both Dominion Income Management and Cornerstone Partners, where he worked on investments as well as mergers and acquisitions for the firms and their portfolio companies. He also spent the early part of his career in banking and public accounting, having held various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation, and as a senior auditor with Arthur Andersen & Company. Herendeen earned a Master of Business Administration (MBA) from the University of Virginia’s Darden School of Business, and holds a bachelor’s degree in Business Administration from Boston College.
Follow Paul Herendeen:
About Bausch Health, Zoetis India Ltd: Zoetis provides healthcare services for animal.
Robert Pietrucha
CFO of Guy Carpenter & Company
Robert Pietrucha is the Chief Financial Officer of Guy Carpenter and a member of the firm’s Board of Managers. Previously, Mr. Pietrucha served as the Finance Director of Marsh’s International Division. Before joining Marsh, Mr. Pietrucha worked with Johnson & Higgins, including assignments within the Controllership and Strategic Planning department, and also worked with Mercer’s corporate finance division. Prior to joining Marsh & McLennan Companies, Mr. Pietrucha worked as a Senior Auditor with Arthur Andersen & Co., where he earned his CPA. Mr. Pietrucha attended Ohio Wesleyan University, where he received a Bachelor of Arts degree in accounting.
Follow Robert Pietrucha:
About Guy Carpenter & Company: Guy Carpenter & Company, LLC operates as a reinsurance intermediary. The company offers accident and health, agriculture, alternative risk
Ethan Einwohner
Chief Financial Officer of Specified Testing Labs
I Ethan Einwohner formed Specified Testing Labs, LLC, a roll-up of environmental testing laboratories, in August 2013. Under Specified, Ethan led the acquisitions of the testing lab assets of: International Hydronics Corporation (Oct 2013); New Jersey Analytical Labs (Nov, 2013), CNA Environmental (Dec 2013); and Smith Environmental Labs (Apr 2014). At Specified, Ethan manages all financial aspects of the firm and has responsibilities for its acquisition and integration activities. With his laboratory operations team, Ethan forms and executes company strategy .
Follow Ethan Einwohner:
About CNA Environmental, Recurrent Capital Bridge Fund, Specified Testing Labs: Specified Testing Laboratories, LLC is a holding company of testing laboratories and related operating companies. Formed in September .
Bill Korn
Chief Financial Officer of CareCloud
Bill Korn joined MTBC in June 2013 as Chief Financial Officer. Mr. Korn has served as CFO for six other businesses, including SnapOne and Antenna Software, where he enabled the business to grow at an 87% CAGR through a combination of acquisitions and organic growth. He also spent ten years with IBM as a member of the senior management team that created IBM’s highly successful services strategy in the 1990’s. Mr. Korn graduated magna cum laude from Harvard College and received his MBA from Harvard Business School.
Follow Bill Korn:
About CareCloud: CareCloud, Inc., formerly MTBC, provides cloud-based technology-enabled software and services for medical practices in the US.
Alexander Casdin
Chief Operating Officer & Chief Financial Officer of Epirium
Alexander Casdin is the Chief Financial Officer (CFO) of Epirium Bio. He has broad financial and operational expertise, with more than 20 years of experience as a healthcare executive and investor. Prior to joining Epirium, Mr. Casdin was founder, Chief Executive Officer (CEO) and portfolio manager of Reneo Capital Management LP, a successful healthcare investment fund. He previously served as CFO of Sophiris Bio, Inc. and Vice President of Finance for Amylin Pharmaceuticals. Mr. Casdin was a founder and senior advisor at Casdin Advisors, LLC; CEO and portfolio manager at Cooper Hill Partners, LLC, a healthcare investment fund; and portfolio manager of Pequot Capital Management’s healthcare fund. Earlier, he worked at the Dreyfus Corporation as a senior managing analyst covering pharmaceuticals, biotechnology and medical devices. Mr. Casdin has been on the board of directors for multiple life science companies including Erasca, Inc., Dusa Pharmaceuticals, Inc., and Ignyta, Inc. Mr. Casdin received an M.B.A from Columbia Business School and a B.A. in political science from Brown University.
Follow Alexander Casdin:
About Epirium, Epirium: Epirium Bio is a clinical stage bio pharmaceutical company.
Robert Glenning
President Financial and Information Technology Services and CFO of Hackensack Meridian Health
Follow Robert Glenning:
About Hackensack Meridian Health: Hackensack Meridian Health is poised to better meet the needs of their communities.
Michael Facendola
Chief Financial Officer of Truveris
Follow Michael Facendola:
About Truveris: Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.
Thomas Etergino
Chief Financial Officer of CareGuardian
Senior financial executive with broad experience in corporate and business unit finance and operations, including in-depth knowledge of technology (SAAS), media, advertising and direct marketing models. – Experienced CFO and COO of both Public, Private Equity and Venture-backed entities. – Broad experience in mergers, acquisitions, and divestitures, as well as corporate debt and equity financing’s, including leading a successful IPO as Chief Financial Officer. – Record of accomplishment in leading organizations through rapid business expansions and contractions. – Extensive international experience – Expertise in the SEC, Sarbanes-Oxley and technical accounting requirements of multinational public companies.
Follow Thomas Etergino:
About CareGuardian: CareGuardian is significantly improving health outcomes through connected caregivers.
David Cordo
CFO of Metamark Genetics
Mr. Cordo began his career in the life sciences industry in 1990. He held senior management positions in finance at Biogen Idec during his seven-year tenure where he put in place the financial infrastructure for the worldwide commercial launch of Avonex. For seven years, he was the Treasurer of Millennium Pharmaceuticals. At Millennium, he led finance teams in the raising of an $800 million follow-on equity offering and a $400 million convertible debt offering. He also led finance teams for three acquisitions. Dave has been interim chief financial officer for several venture capital backed life science companies, including Dicerna Pharmaceuticals, Epizyme, Inc., Link Medicine Corporation, TransForm Pharmaceuticals, Avila Therapeutics and Alinea Pharmaceuticals, and consulting on strategic financial issues for public and private life science companies. He is a Certified Public Accountant and holds an M.B.A. degree from Nichols College and a B.S.B.A. degree from Stonehill College. He is an active member of the Executive Committee of the Wake Forest University Parents’ Council and consults for several charitable organizations.
Follow David Cordo:
About Metamark Genetics, Novartis, Potenza Therapeutics, Semma Therapeutics: Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.
Matthew Stack
Chief Financial Officer of Koning
Matt Stack is a founder of XLP Capital, the founding manager of the Lambda Prime Investment Incubator Fund, and the Chief Investment Officer of XLP’s technology activist fund, Devonshire Capital Fund I. He is an experienced early and seed stage investor in high tech hardware and analytics companies with over $200M in completed deals, and serves as a technology advisor to a variety of institutions and family offices overseeing and directing over $500M. Over the past decade, Matt has acquired and developed a collection of minority interests in companies across North America ranging from small university spin outs to mid-sized industrial technology companies. Matt serves as an advisor to a number of privately held companies, where he manages and supervises technology and high performance computing investments. Matt has served as the Director of Computational Science at Mars Corporation and as a Partner at 3LP – a Boston-based elite Intellectual Property advisory firm. Matt’s prior experiences include managing acquisitions for a $120M corporate-led technology buyout fund in Palo Alto, as well as spending 6 years at The Boston Consulting Group in the Boston and New York offices, where he worked on projects in the Health Care, IT, Retail, Industrial Goods, and Strategy practice areas. He frequently helped corporate clients with topics including corporate growth strategy, merger and acquisitions, and post-merger integration. Before BCG, Matt co-founded and invested in a health care software startup, a small electronics company, an advanced composites design firm, and a semiconductor distribution company that traded high performance semiconductor chips between Shenzhen, Tokyo, and Tecate. Matt holds a B.S.E. in electrical engineering from Princeton University. He is a benefactor and sponsor of the TEDx conference series, and has sponsored research at the Santa Fe Institute in New Mexico, the Strategy Institute in New York, MIT’s Broad Institute, the Highlands Forum, the University of Oxford, and the Department of Defense. He is an accomplished computer hacker and cryptanalyst, and has written and advised on state-run network cyber-warfare policy, and agility-based strategic combat. Matt was recognized in 2009 by Hackaday as one of the top 10 most influential hardware hackers, and has been featured in Wired Magazine and the Wall Street Journal for his hobby electronics projects. He is the author of 11 neuroscience patents covering devices, analytical methods, and algorithms for detecting concussion and improving cognitive performance. In his spare time, he has been an Olympic hopeful in javelin, a competitive speedskater, a motorcycle collector, and is currently a professional windsurfer.
Follow Matthew Stack:
About Koning, XLP Capital: 3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
Melissa Epperly
Chief Financial Officer of Psioxus Therapeutics
Melissa Epperly is a senior finance executive with deep healthcare experience. Prior to joining PsiOxus, Melissa was CFO and Head of Business Development at R-Pharm US, a commercial-stage oncology pharmaceutical company based in Princeton, NJ. At R-Pharm US she led corporate and business development, leading the integration of the asset purchase of Ixempra ® (a metastatic breast cancer treatment) from Bristol-Myers Squibb. Previously, Melissa was a Director at Anchorage Capital Group, a credit-focused hedge fund, where she drove operational excellence in their portfolio companies to facilitate and enable exponential growth. Prior to that she was a Vice President at Goldman Sachs in equity research where she helped develop, build, and commercialize a novel, global equity research product for long-term investing, GS SUSTAIN, in the US and Europe. Before joining Goldman Sachs she was a management consultant with Bain & Company in New York and London, focused on international and US based pharmaceutical clients and private equity. She previously worked at Morgan Stanley in New York in healthcare investment banking and banking management, enabling pharmaceutical and biotech companies to accelerate growth through strategic MandA and capital raising. Melissa holds an MBA from Harvard Business School and BA in Biochemistry and Economics from the University of Virginia, where she graduated Phi Beta Kappa.
Follow Melissa Epperly:
About Psioxus Therapeutics: Psioxus Therapeutics is a cancer gene therapy company delivers medicines of value to patients with cancer.
Garrick Bernstein
Chief Financial Officer of OneOncology
Garrick Bernstein is Chief Financial Officer at One Medical. As the chief financial officer, Garrick oversees all financial matters for the company and leads the teams responsible for financial planning and analysis, accounting, and investment strategy. Garrick brings extensive operational finance, private equity, and capital market experience. Most recently, he was executive vice president and CFO of HealthGrades. Prior to HealthGrades, Garrick was a principal and investment professional at Vestar Capital Partners, working on numerous management buyouts, recapitalizations, and growth equity investments, and he served as a member of the board of directors for several Vestar companies.
Follow Garrick Bernstein:
About OneOncology: OneOncology is a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the US.
Steven Paladino
EVP & CFO of Henry Schein, Inc
Follow Steven Paladino:
About Henry Schein, Inc: Henry Schein, Inc. is the world’s largest provider of health care products and services to office-based dental, medical and animal health
Eric Brody
CFO, COO & Co-Founder of Qinetic
Eric Brody, CFO, COO and Co-founder of Qinetic, has always focused on living and leading a healthy lifestyle after being diagnosed with Chron’s disease in High School. He is a Level III CFA Candidate and has several years experience in corporate finance and banking while working at Citigroup and the Federal Reserve Bank of New York. He is an active fitness enthusiast and has completed two Tough Mudders.Eric has a B.S. in Finance and Economics from Manhattan College.
Follow Eric Brody:
About Qinetic: Qinetic streams live fitness classes from coaches and trainers of the fitness industry.
Peter Balash
Chief Financial Officer of Rochester Optical
Since April 2005, Peter Balash has been Rochester Optical’s CFO, head of the accounting and military departments. He is responsible for sales, production, inventory, quality control, and much more. When Peter started in 2005, Rochester Optical was a four million dollar company with 40 employees. As of 2014, the business has grown into a twenty million dollar company with 215 employees. Prior to working at Rochester Optical, Peter ran an employee owned printing company with 120 employees and eleven million dollars in sales. Outside of work, Peter loves entertaining with his family and friends at his home including his two Weimaraner dogs, Zeke and Luca.
Follow Peter Balash:
About Rochester Optical: Rochester Optical manufactures optical frames and lenses.
Tomer Benami
Chief Financial Officer of VirtualHealth
Follow Tomer Benami:
About KPMG International Limited, VirtualHealth: The only care management platform purpose-built for value-based care. Our vision is proactive healthcare for all.
O. James Sterling
Chief Financial Officer of Renalytix AI
Follow O. James Sterling:
About Renalytix AI: RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease.
Roger Sawhney
Chief Financial Officer of Omega Therapeutics
Roger Sawhney is the Chief Financial Officer at Omega Therapeutics.
Follow Roger Sawhney:
About Omega Therapeutics: Omega Therapeutics offers a proprietary epigenomic programming platform.
Isaac Miller
CFO, Co-Founder of Cresilon, Inc.
Isaac co-founded Suneris and is responsible for all financial operations. He directs Suneris’ business initiatives and manages investor relations. Through financial analysis and forecasting, Isaac devises and implements strategic financial plans that maximize assets and foster growth at Suneris. Currently, he is an Innovation Consultant at NYU Polytechnic School of Engineering. Isaac holds a BS in Finance and Management from NYU Stern School of Business.
Follow Isaac Miller:
About Cresilon, Inc.: Cresilon is a medical device company that produces and markets solutions for trauma care.
Julie Oh
CFO of Performance Logic
Follow Julie Oh:
About Performance Logic: Healthcare Project Management and Rounding Software in the cloud
Kim Holland
Chief Financial Officer of Healthcare Triangle
Ms. Holland is a finance professional with over 30 years of diverse experience, including accounting, audit, controllership, budgeting, and financial reporting. Prior to joining Cornerstone Advisors, she managed her own accounting practice specializing in individual and small business taxation, bookkeeping, and payroll administration. Ms. Holland began her career with GTE (now Verizon), a Fortune 100 telecommunications company, where she worked for 11 years in a variety of staff and leadership positions. She later served as the controller for a document imaging company. Ms. Holland has a Bachelor of Science in Accounting from the University of Tampa and a Master of Business Administration from Fairleigh Dickinson University. She is a Certified Public Accountant, a Certified Financial Planner, and is a member of the American Institute of Certified Public Accountants (AICPA).
Follow Kim Holland:
About Healthcare Triangle: Healthcare Triangle is committed to supporting healthcare providers, hospitals, health systems, and pharmaceutical companies.
Puneet Sapra
Chief Financial Officer of StayWell Company
Follow Puneet Sapra:
About Frontida Biopharm, MBX Capital, StayWell Company: StayWell is a health engagement company that helps its clients engage and educate people to improve health and business results.
Laura Schulhof
CFO of Ambra Health
Laura drives the financial and accounting, legal and HR functions of Ambra Health with a strong background in strategic finance. Prior to joining Ambra in January 2017, Laura was Chief of Staff of the CEO at Endurance International, a publicly-traded SaaS hosting and IT services business for SMBs. While there, she worked closely with the functional leaders of each department and focused finance and operations for the company’s growth ventures. She also worked closely with the BD, Finance and Legal teams to complete the acquisition of Constant Contact in 2015. Prior to joining Endurance in 2015, Laura was an investment banker for Credit Suisse in the Technology group based in San Francisco. While there, Laura was a part of many IPOs, equity and debt financings (including of EIGI) and M&A transactions on both the buy and sell side. Laura is a graduate of Princeton University.
Follow Laura Schulhof:
About Ambra Health: Ambra Health is a medical data and image management SaaS provider company.
Benjamin Newmark
President & CFO of SolasCure
Benjamin Newmark is the Founder, President, and CFO at SolasCure.
Follow Benjamin Newmark:
About Better.com, SolasCure: Solascure is a biotechnology company focused on the development of fit for purpose, efficacious wound care products.
James Cerveaux
Chief Financial Officer of CDx Diagnostics
Jimmy Cerveaux brings C-level executive experience with deep financial expertise acquired at blue chip companies and as an entrepreneur. He co-founded, led and sold Unicity Eldercare, a successful 150 employee healthcare company located in NY & NJ. Mr. Cerveaux also worked for many years as an Auditor and a Mergers & Acquisitions Consultant at Ernst & Young, and as an equity analyst for a leading investment management firm in the Middle East. He is a graduate of Massachusetts Institute of Technology in Cambridge, MA.
Follow James Cerveaux:
About CDx Diagnostics: CDx Diagnostics develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells.
Dennis M. O’Leary
Chairman, Founder, CEO, and CFO of DarkPulse
Dennis O’Leary is the Chairman, Founder, CEO, and CFO of DarkPulse.
Follow Dennis M. O’Leary:
About DarkPulse: DarkPulse uses advanced laser-based monitoring systems to provide rapid and accurate monitoring of temperatures, strains and stresses.
Jim Walsh
Chief Financial Officer of Noble Biomaterials
Mr. Walsh has 30 years of business experience and began his career as a certified public accountant. Jim entered the private manufacturing sector in 1983 by joining Instrument Specialties Co., a premier provider of RFI/EMI shielding solutions, where he served in several operational and financial roles. In 2000, Mr. Walsh managed the offering and sale of Instrument Specialties for $285 million. Jim joined Noble in 2005. Jim holds a Bachelor’s degree in accounting from the University of Scranton in Pennsylvania.
Follow Jim Walsh:
About Noble Biomaterials: Noble creates intelligent materials designed to PROTECT, SAVE, HEAL, and IMPROVE LIVES
Yousef Al-Humaidhi
CFO & Co-Founder of Mighty Well
Follow Yousef Al-Humaidhi:
About Mighty Well: Mighty Well creates sportswear inspired Adaptive Wear to help those living with chronic conditions to turn sickness into strength
Graham Anderson
COO/CFO of Koios Medical
Proven investor, consultant, and start-up manager who possesses a strong combination of strategic thinking and execution ability. Analytically oriented with exposure to many areas within the information technology and life sciences markets with particular emphasis on enterprise software, information services, healthcare IT, specialty pharmaceuticals, and aesthetics. Hands on operating experience working with entrepreneurs enables realistic assessments of investment opportunities and risks. Skilled negotiator with experience selling products and services, raising and placing capital, and sourcing strategic and financial M&A transactions. I want to work and invest with interesting and exciting people who are looking for great companies and opportunities. Together we will find them and help create them. Specialties:Structuring venture capital deals; Corporate board committee experience — Audit, Compensation, Corporate Governance and Nominating Committees; Business and corporate development experience; Enterprise sales; Investment banking liaison; CFA Charterholder.
Follow Graham Anderson:
About Koios Medical: Koios Medical is a leading healthcare into the era of machines & supporting physicians in delivering exceptional care.
Brian Douglas
CFO of Protein2o
Follow Brian Douglas:
About Protein2o: Protein2o provides drinks that promote a healthy, active lifestyle through the daily use of protein.
Mark Corrao
Chief Financial Officer of Kannalife
Follow Mark Corrao:
About Kannalife: Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.
Alan A. Bucher,
Chief Financial Officer of Getinge
Alan A. Bucher is the Chief Financial Officer at Getinge.
Follow Alan A. Bucher,:
About Getinge: Getinge identifies customer issues and promotes clinical and economic benefits and follow and support the customer decision process.
Chris Dorsey
CFO and COO of Getinge
Chris Dorsey is the CFO and COO at Getinge.
Follow Chris Dorsey:
About Getinge: Getinge identifies customer issues and promotes clinical and economic benefits and follow and support the customer decision process.
Matt Kapusta
Chief Financial Officer of UniQure
Matt Kapusta joined uniQure as CFO in January 2015 with nearly 20 years of experience in the life sciences industry. Most recently, Matt was Senior Vice President at AngioDynamics responsible for corporate development, strategic planning and national accounts. Prior to AngioDynamics, he served as Vice President, Finance for Smith & Nephew Orthopaedics. Matt’s career also includes more than a decade of investment banking experience focused on emerging life sciences companies. Matt was Managing Director, Healthcare Investment Banking at Collins Stewart, and held various positions at Wells Fargo Securities, Robertson Stephens and PaineWebber. Matt holds a Master of Business Administration from New York University’s Stern School of Business, a Bachelor of Business Administration from University of Michigan’s Ross School of Business and earned his Certified Public Accountant license in 1996 while at Ernst & Young.
Follow Matt Kapusta:
About UniQure: uniQure is focused on the research and early development of human gene-based therapies.
Carl Hubenak
CFO of Pleatco
Follow Carl Hubenak:
About Pleatco: Pleatco has served the pool & spa community for 44 years and leads the industry.
Jing Moore
Vice President of Finance & CFO of Waiting Room Solutions
Follow Jing Moore:
About Waiting Room Solutions: WRS Health provides a fully integrated, web-based electronic medical record (EHR) and practice management solutions for medical practices.
Richard Friedman
CFO of Voicebrook
Follow Richard Friedman:
About Voicebrook: Voicebrook is the leading provider of speech recognition and reporting solutions for pathologists.
Regina Reale
CFO of Cecelia Health
Regina Reale is the Chief Financial Officer at Cecelia Health.
Follow Regina Reale:
About Cecelia Health: Cecelia Health is a health-tech company that connects clinical coaching and proprietary technology with people living with diabetes.
Marc Eigg
Managing Partner & CFO & WROG’s Director of Urogynecology & Pelvic Reconstructive Surgery of West Ridge Obstetrics & Gynecology
Eigg is double Board Certified in both Obstetrics and Gynecology as well as in Female Pelvic Medicine and Reconstructive Surgery. He serves as WROG’s Director of Urogynecology & Pelvic Reconstructive Surgery. Eigg is also an Associate Clinical Professor of Ob-Gyn at the University of Rochester School of Medicine, teaches Urogynecology for the Rochester General Hospital independent Ob-Gyn Residency program and is an Assistant Professor of Ob/Gyn with Saba University.Eigg has taught advanced robotic reconstructive pelvic surgery since 2005. Eigg has made many teaching presentations at the American Association of Gynecologic Laparoscopists. He is a graduate of Cornell University where he did clinical research that is published in the Journal of Neurosciences.Eigg finds professional satisfaction relieving the suffering of his patients as a result of surgically repairing pelvic organ prolapse, gynecologic fistulae or curing urinary incontinence and/or pelvic pain.
Follow Marc Eigg:
About Saba University School of Medicine , University of Rochester Medical Center, West Ridge Obstetrics & Gynecology: West Ridge Obstetrics & Gynecology, our group of board certified physicians, licensed nurse practitioners and caring staff.